Skip to main content
Top
Published in: Current HIV/AIDS Reports 3/2015

01-09-2015 | Complications of Antiretroviral Therapy (JM Kilby, Section Editor)

Eosinophilia in Patients Infected with Human Immunodeficiency Virus

Authors: Andrew Chou, Jose A. Serpa

Published in: Current HIV/AIDS Reports | Issue 3/2015

Login to get access

Abstract

Eosinophilia is not uncommonly encountered in patients infected with human immunodeficiency virus (HIV), particularly at initiation of care or among those with advanced disease. The clinical manifestation most commonly associated with eosinophilia in this patient population is skin rash. Management of these patients is challenging due to a paucity of data evaluating diagnostic testing and therapeutic strategies. Patients born in or with significant travel to parasite-endemic countries are more likely to have tissue-invasive helminthes, such as Strongyloides or Schistosoma. Patients without such risk factors are unlikely to have parasitic infections and frequently will have self-resolution of eosinophilia. When a detailed history, physical exam, and diagnostic work-up are unrevealing, we sometimes consider empirical therapy with ivermectin. Praziquantel may also be considered for those at risk for schistosomiasis.
Literature
1.••
go back to reference Sivaram M, White A, Radcliffe KW. Eosinophilia: clinical significance in HIV-infected individuals. Int J STD AIDS. 2012;23:635–8. Study examining the relationship between eosinophilia and parasitic infections in patients with HIV.PubMedCrossRef Sivaram M, White A, Radcliffe KW. Eosinophilia: clinical significance in HIV-infected individuals. Int J STD AIDS. 2012;23:635–8. Study examining the relationship between eosinophilia and parasitic infections in patients with HIV.PubMedCrossRef
2.
go back to reference Cohen AJ, Steigbigel RT. Eosinophilia in patients infected with human immunodeficiency virus. J Infect Dis. 1996;174:615–8.PubMedCrossRef Cohen AJ, Steigbigel RT. Eosinophilia in patients infected with human immunodeficiency virus. J Infect Dis. 1996;174:615–8.PubMedCrossRef
3.
go back to reference Adewuyi JO, Coutts AM, Latif AS, Smith H, Abayomi AE, Moyo AA. Haematologic features of the human immunodefiency virus (HIV) infection in adult Zimbabweans. Central African Journal of Medicine. 1999;45:26–9. Adewuyi JO, Coutts AM, Latif AS, Smith H, Abayomi AE, Moyo AA. Haematologic features of the human immunodefiency virus (HIV) infection in adult Zimbabweans. Central African Journal of Medicine. 1999;45:26–9.
5.•
go back to reference Mejia R, Nutman TB. Evaluation and differential diagnosis of marked, persistent eosinophilia. Semin Hematol. 2012;49:149–59. Differentiates which parasitic infections typically cause eosinophilia. PubMedCentralPubMedCrossRef Mejia R, Nutman TB. Evaluation and differential diagnosis of marked, persistent eosinophilia. Semin Hematol. 2012;49:149–59. Differentiates which parasitic infections typically cause eosinophilia. PubMedCentralPubMedCrossRef
6.••
go back to reference Mohajer Al M, Villarreal-Williams E, Andrade RA, Giordano TP, Serpa JA. Eosinophilia and associated factors in a large cohort of patients infected with human immunodeficiency virus. South Med J. 2014;107:554–8. Study examining the factors associated with eosinophilia in patients with HIV. Most patients had resolution of eosinophilia. CrossRef Mohajer Al M, Villarreal-Williams E, Andrade RA, Giordano TP, Serpa JA. Eosinophilia and associated factors in a large cohort of patients infected with human immunodeficiency virus. South Med J. 2014;107:554–8. Study examining the factors associated with eosinophilia in patients with HIV. Most patients had resolution of eosinophilia. CrossRef
7.
go back to reference Fabre V, Beiting DP, Bliss SK, Gebreselassie NG, Gagliardo LF, Lee NA, et al. Eosinophil deficiency compromises parasite survival in chronic nematode infection. J Immunol. 2009;182:1577–83.PubMedCentralPubMedCrossRef Fabre V, Beiting DP, Bliss SK, Gebreselassie NG, Gagliardo LF, Lee NA, et al. Eosinophil deficiency compromises parasite survival in chronic nematode infection. J Immunol. 2009;182:1577–83.PubMedCentralPubMedCrossRef
8.
go back to reference Harley WB, Blaser MJ. Disseminated coccidioidomycosis associated with extreme eosinophilia. Clin Infect Dis. 1994;18:627–9.PubMedCrossRef Harley WB, Blaser MJ. Disseminated coccidioidomycosis associated with extreme eosinophilia. Clin Infect Dis. 1994;18:627–9.PubMedCrossRef
9.
go back to reference Porter P, Polikepahad S, Qian Y, Morgan Knight J, Lu W, Tai WMT, et al. Respiratory tract allergic disease and atopy: experimental evidence for a fungal infectious etiology. Med Mycol. 2011;49:S158–63.PubMedCentralPubMedCrossRef Porter P, Polikepahad S, Qian Y, Morgan Knight J, Lu W, Tai WMT, et al. Respiratory tract allergic disease and atopy: experimental evidence for a fungal infectious etiology. Med Mycol. 2011;49:S158–63.PubMedCentralPubMedCrossRef
10.
go back to reference Arndt MB, John-Stewart G, Richardson BA, Singa B, van Lieshout L, Verweij JJ, et al. Impact of helminth diagnostic test performance on estimation of risk factors and outcomes in HIV-positive adults. PLoS ONE. 2013;8, e81915.PubMedCentralPubMedCrossRef Arndt MB, John-Stewart G, Richardson BA, Singa B, van Lieshout L, Verweij JJ, et al. Impact of helminth diagnostic test performance on estimation of risk factors and outcomes in HIV-positive adults. PLoS ONE. 2013;8, e81915.PubMedCentralPubMedCrossRef
11.
go back to reference Wongkitisophon P, Vachiramon V, Chanprapaph K, Rattanakaemakorn P. Six-year retrospective review of drug reaction with eosinophilia and systemic symptoms. Acta Derm Venereol. 2012;92:200–5.PubMedCrossRef Wongkitisophon P, Vachiramon V, Chanprapaph K, Rattanakaemakorn P. Six-year retrospective review of drug reaction with eosinophilia and systemic symptoms. Acta Derm Venereol. 2012;92:200–5.PubMedCrossRef
13.
go back to reference Perry MEO, Almaani N, Desai N, Larbalestier N, Fox J, Chilton D. Raltegravir-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome—implications for clinical practice and patient safety. Int J STD AIDS. 2013;24:639–42.PubMedCrossRef Perry MEO, Almaani N, Desai N, Larbalestier N, Fox J, Chilton D. Raltegravir-induced drug reaction with eosinophilia and systemic symptoms (DRESS) syndrome—implications for clinical practice and patient safety. Int J STD AIDS. 2013;24:639–42.PubMedCrossRef
14.
go back to reference Tietz A, Sponagel L, Erb P, Bucher H, Battegay M, Zimmerli W. Eosinophilia in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis. 1997;16:675–7.PubMedCrossRef Tietz A, Sponagel L, Erb P, Bucher H, Battegay M, Zimmerli W. Eosinophilia in patients infected with the human immunodeficiency virus. Eur J Clin Microbiol Infect Dis. 1997;16:675–7.PubMedCrossRef
15.
go back to reference Skiest DJ, Keiser P. Clinical significance of eosinophilia in HIV-infected individuals. Am J Med. 1997;102:449–53.PubMedCrossRef Skiest DJ, Keiser P. Clinical significance of eosinophilia in HIV-infected individuals. Am J Med. 1997;102:449–53.PubMedCrossRef
16.
go back to reference Hochberg NS, Moro RN, Sheth AN, Montgomery SP, Steurer F, McAuliffe IT, et al. High prevalence of persistent parasitic infections in foreign-born. HIV-infected persons in the United States. PLoS Negl Trop Dis. 2011;5, e1034.PubMedCentralPubMedCrossRef Hochberg NS, Moro RN, Sheth AN, Montgomery SP, Steurer F, McAuliffe IT, et al. High prevalence of persistent parasitic infections in foreign-born. HIV-infected persons in the United States. PLoS Negl Trop Dis. 2011;5, e1034.PubMedCentralPubMedCrossRef
17.••
go back to reference Costiniuk CT, Cooper CL, Doucette S, Kovacs CM. Parasitic disease screening among HIV patients from endemic countries in a Toronto clinic. Can J Infect Dis Med Microbiol. 2012;23:23–7. Study of the prevalence of parasitic infections in patients with HIV from parasite-endemic countries. PubMedCentralPubMed Costiniuk CT, Cooper CL, Doucette S, Kovacs CM. Parasitic disease screening among HIV patients from endemic countries in a Toronto clinic. Can J Infect Dis Med Microbiol. 2012;23:23–7. Study of the prevalence of parasitic infections in patients with HIV from parasite-endemic countries. PubMedCentralPubMed
18.
go back to reference Poon KK, Dang BN, Davila JA, Hartman C, Giordano TP. Treatment outcomes in undocumented Hispanic immigrants with HIV infection. PLoS ONE. 2013;8, e60022.PubMedCentralPubMedCrossRef Poon KK, Dang BN, Davila JA, Hartman C, Giordano TP. Treatment outcomes in undocumented Hispanic immigrants with HIV infection. PLoS ONE. 2013;8, e60022.PubMedCentralPubMedCrossRef
Metadata
Title
Eosinophilia in Patients Infected with Human Immunodeficiency Virus
Authors
Andrew Chou
Jose A. Serpa
Publication date
01-09-2015
Publisher
Springer US
Published in
Current HIV/AIDS Reports / Issue 3/2015
Print ISSN: 1548-3568
Electronic ISSN: 1548-3576
DOI
https://doi.org/10.1007/s11904-015-0272-x

Other articles of this Issue 3/2015

Current HIV/AIDS Reports 3/2015 Go to the issue

Co-infections and Comorbidity (S Naggie, Section Editor)

Acute HCV in HIV-Infected MSM: Modes of Acquisition, Liver Fibrosis, and Treatment

Complications of Antiretroviral Therapy (JM Kilby, Section Editor)

The Role of Statins in the Setting of HIV Infection

Co-infections and Comorbidity (S Naggie, Section Editor)

The Role of Viral Co-Infection in HIV-Associated Non-AIDS-Related Cancers

Co-infections and Comorbidity (S Naggie, Section Editor)

Emerging Challenges in Managing Hepatitis B in HIV Patients

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine